During an internal meeting to mark the end of the year, a colleague from our Nucleofector® Sales Team shared a story which touched our hearts deeply. This story really shows why we love our jobs and therefore we would like to share this with you. And it goes like this:
"My maternal grandmother died from complications of diabetes when I was a junior in high school. Six months later, when I started my senior year of high school, my paternal grandmother died after her colon cancer metastasized. So, I have a vested interest in helping move research forward, especially cancer research…"
Further on this, the colleague reported that in the last few days she was in close contact with one of her customers having issues with their 4D-Nucleofector® LV Unit failing to transfect cells from a patient. Currently, this lab is running an important clinical trial for cancer treatment, for patients who have not responded to earlier therapies. Luckily, the patient yielded enough cells so that there was a "spare" billion cells to try again. Just one more try.
At this point it was more than important to connect to our Engineering Team to check for their experience and feedback on the issue observed in the first attempt. One of our engineers analyzed the results from the first trial and explained that the observed issue seemed to be more related to a handling issue rather than to the device itself and she wound up Face Timing with the researchers as they ran the remaining cells immediately after the call to support them in their second trial. The cells were transfected successfully and could be used for treatment.
"Which means that our technology – our engineering of the 4D-Nucleofector® LV Unit, all of the training we’ve received, each of us, were part of giving this patient another shot at life.
I cannot tell you how much it means to me that we have been entrusted with this responsibility. Nor can I express my pride, doubt, fear, and excitement at being part of this!
I have watched cancer eat away people I love and it sucks! It is very fulfilling to be a part of the solution in being able to help someone fight, even though we won’t meet that person. And I just want to say thank you! Because someday, it might be me and it’s very comforting to know that there’s an army behind the frontline of healthcare workers working towards making a possible cure."
To protect the privacy of everyone involved, some details have been adapted.
Story shared by the Sales Team and written by SST and Marketing
Lonza Pharma-Bioscience Solutions at Lonza